{"schema_version":"secwatch.filing_event.v1","accession":"0001829126-25-008902","form_type":"8-K","ticker":"NTHI","cik":"0001979414","company_name":"NEONC TECHNOLOGIES HOLDINGS, INC.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.204675+00:00","generated_at":"2026-05-17T00:02:59.292145+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NeOnc Technologies appoints Amir Heshmatpour as CEO; founder Dr. Thomas Chen transitions to CMO/CSO","bullets":["Dr. Thomas Chen resigns as CEO, becomes Chief Medical Officer and Chief Scientific Officer, retains Vice Chairman role.","Amir Heshmatpour appointed CEO effective Oct 31, 2025, in addition to President and Executive Chairman roles.","Heshmatpour to receive $1/year salary and 1.2M restricted stock shares with vesting schedule.","Press release highlights $50M strategic partnership with Quazar Investment and expansion of Scientific Advisory Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-25-008902","json":"https://secwatch.observer/filing/0001829126-25-008902.json","markdown":"https://secwatch.observer/filing/0001829126-25-008902.md","text":"https://secwatch.observer/filing/0001829126-25-008902.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1979414/000182912625008902/0001829126-25-008902-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1979414/000182912625008902/neonctechnologies_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:02:59.292145+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}